Damora Therapeutics (DMRA) Current Assets (2019 - 2026)
Damora Therapeutics (DMRA) posted Current Assets of $535.4 million for Q1 2026, up 105.59% on a QoQ basis from $260.4 million in Q4 2025, and up 3493.29% year-over-year from $14.9 million in Q1 2025.
Damora Therapeutics (DMRA) Current Assets (2019 - 2026) Analysis & Trends
Damora Therapeutics' Current Assets history runs 8 years deep, the most recent figure standing at $535.4 million for Q1 2026.
- Quarterly Current Assets rose 3493.29% year-over-year to $535.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $535.4 million (up 3493.29% YoY) and the FY2025 annual result came in at $260.4 million, up 1450.14% from the prior year.
- Current Assets was $535.4 million for Q1 2026 at Damora Therapeutics, up from $260.4 million in the prior quarter.
- Across five years, Current Assets topped out at $535.4 million in Q1 2026 and bottomed at $9.8 million in Q3 2025.
- A 5-year average of $84.6 million and a median of $47.1 million in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets sank 54.95% — and 2026, when it surged 3493.29%.
- Damora Therapeutics' Current Assets stood at $63.9 million in 2022, then slumped by 42.45% to $36.8 million in 2023, then tumbled by 54.32% to $16.8 million in 2024, then soared by 1450.14% to $260.4 million in 2025, then jumped by 105.59% to $535.4 million in 2026.
- Business Quant data shows DMRA's Current Assets at $535.4 million in Q1 2026, $260.4 million in Q4 2025, and $9.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Damora Therapeutics | 1.00 Bn | 798.11 Mn | - | 535.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 535.40 Mn |
| Dec 31, 2025 | 260.42 Mn |
| Sep 30, 2025 | 9.80 Mn |
| Jun 30, 2025 | 13.03 Mn |
| Mar 31, 2025 | 14.90 Mn |
| Dec 31, 2024 | 16.80 Mn |
| Sep 30, 2024 | 21.20 Mn |
| Jun 30, 2024 | 25.20 Mn |
| Mar 31, 2024 | 30.50 Mn |
| Dec 31, 2023 | 36.77 Mn |
| Sep 30, 2023 | 47.05 Mn |
| Jun 30, 2023 | 55.40 Mn |
| Mar 31, 2023 | 57.10 Mn |
| Dec 31, 2022 | 63.90 Mn |
| Sep 30, 2022 | 71.20 Mn |
| Jun 30, 2022 | 82.20 Mn |
| Mar 31, 2022 | 97.03 Mn |
| Dec 31, 2021 | 110.10 Mn |
| Sep 30, 2021 | 107.00 Mn |
| Jun 30, 2021 | 107.71 Mn |